Schizophrenia meds
olanzapine
haloperidol (haldol)
Olanzapine
MOA, AV, Pt. edu
MOA:
- produce moderate blockade of dopamine
AV:
- weight gain
- diabetes
Pt. edu:
- report signs of chest pain, dyspnea, tachycardia
Haldol
MOA, AV, Pt. edu
MOA:
- blocks dopamine
AV:
- acute dystonia
- pseudo parkinsonism
- tardive dyskinesia
Pt. edu:
- high potency is preferred as initial treatment
Depression meds
(SSRI’s)
Sertraline (zoloft)
Duloxetine
Sertraline (Zoloft)
MOA, AV, Pt. edu
MOA:
- inhibits serotonin reuptake
AV:
- sexual dysfunction
- sleepiness
- weigh gain
Pt. edu:
- therapeutic effects seen in 10-20 days
Duloxetine
MOA, AV, Pt. edu
MOA:
- inhibits serotonin and nor epi re-uptake
AV:
- insomnia
- blurred vision
- anorexia
Pt. edu:
- wean off slowly
- therapeutic effects seen in 2-4 weeks
MAOI’s
Selegiline
Selegiline
MOA, AV, Pt. edu
MOA:
- blocks MAO in the brain (causing the increase of nor epi)
AV:
- CNS stimulation
- ortho. hypotension
Pt. edu:
- increases the risk of serotonin syndrome
2/3 choice due to dangerous S/E
Atypical antidepressants
Bupropion (wellbutrin)
Bupropion (wellbutrin)
MOA, AV, Pt. edu
MOA:
- unclear but related to blockage of dopamine
AV:
- drug has stimulant actions and suppresses appetite
Pt. edu:
- effects seen in 1-3 weeks
- may cause appetite suppression
Bipolar disorder meds
lithium carbonate
lithium carbonate
MOA, AV, Pt. edu
MOA:
- alters distrubution of certain ions
AV:
Pt. edu:
anxiety medications
lorazepam
diazepam
lorazepam
diazepam
MOA, AV, Pt. edu
MOA:
AV:
Pt. edu:
ADHD meds
methylphenidate
methylphenidate
MOA, AV, Pt. edu
MOA:
AV:
Pt. edu: